Status:
COMPLETED
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes
Lead Sponsor:
Ciusss de L'Est de l'Île de Montréal
Collaborating Sponsors:
Juvenile Diabetes Research Foundation
Institut de Recherches Cliniques de Montreal
Conditions:
Type 1 Diabetes
Exocrine Pancreatic Insufficiency
Eligibility:
All Genders
18+ years
Brief Summary
This study proposes to examine the contribution of CFTR variants to exocrine pancreatic insufficiency and hypoglycemic risk. Hypoglycemia is one the most frequent complications of type 1 diabetes mana...
Detailed Description
In this a one year cross sectional study, we plan to enroll 100 adults living with type 1 diabetes. Patient data will then be separated into two groups based the presence or absence of exocrine pancr...
Eligibility Criteria
Inclusion
- Type 1 diabetes
- Living in Montreal
Exclusion
- Pregnancy,
- Use of corticosteroid
- Use of medication known to have a relevant impact on glycemic control.
Key Trial Info
Start Date :
April 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05385211
Start Date
April 30 2022
End Date
August 30 2023
Last Update
September 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de recherches cliniques de Montréal
Montreal, Quebec, Canada, H2